HER 2 POSITIVE BREAST CANCER
Clinical trials for HER 2 POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER 2 POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER 2 POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat breast cancer: A166 targets tumors after other therapies fail
Disease control Recruiting nowThis study tests a drug called A166 in 40 adults with HER2-positive breast cancer that has spread and no longer responds to standard treatments. Participants must have already tried a type of antibody-drug conjugate (TOP1-ADC). The goal is to see if A166 can shrink tumors or slow…
Matched conditions: HER 2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Biosimilar breast cancer drug under Real-World microscope
Disease control Recruiting nowThis study follows 1,000 people with HER2-positive breast cancer to see how a biosimilar version of pertuzumab is used in routine treatment, either before surgery or for advanced disease. Researchers will track treatment patterns, how well the drug works, and any side effects. Th…
Matched conditions: HER 2 POSITIVE BREAST CANCER
Sponsor: Société Algérienne de Formation et Recherche en Oncologie • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC